{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:12Z","timestamp":1791389112235,"version":"4.3.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11060-026-05522-6","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:23:42Z","timestamp":1775823822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pubertal development and hormonal modulation in pediatric low-grade gliomas: a retrospective cohort study"],"prefix":"10.1007","volume":"177","author":[{"given":"Federica","family":"D\u2019Antonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Carai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna S.","family":"Colafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"D\u2019Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Megaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada Del","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"5522_CR1","doi-asserted-by":"crossref","unstructured":"Van Heerden J, Esterhuizen TM, Jbebli E, Fedhila F, Rhayem S, Chabchoub I et al. (2025 Feb 13) Pediatric low-grade glioma in Africa: a baseline study before the implementation of global initiative for childhood Cancer strategies. Front Cancer control Soc [Internet]. 3 Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fcacs.2025.1528695\/full [cited 2025 Jul 16]","DOI":"10.3389\/fcacs.2025.1528695"},{"issue":"2","key":"5522_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbcan.2014.02.004","volume":"1845","author":"G Bergthold","year":"2014","unstructured":"Bergthold G, Bandopadhayay P, Bi WL, Ramkissoon L, Stiles C, Segal RA et al. (2014 Apr) Pediatric low-grade gliomas: how modern biology reshapes the clinical field. Biochim Biophys Acta BBA - Rev Cancer 1845(2):294\u2013307","journal-title":"Biochim Biophys Acta BBA - Rev Cancer"},{"issue":"10","key":"5522_CR3","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00381-024-06619-x","volume":"40","author":"S Constantini","year":"2024","unstructured":"Constantini S, Bouffet E, Schuhmann MU (2024 Oct) Pediatric low-grade gliomas. Childs Nerv Syst 40(10):3001\u20133001","journal-title":"Childs Nerv Syst"},{"key":"5522_CR4","doi-asserted-by":"crossref","unstructured":"Crotty EE, Sato AA, Abdelbaki MS (2025 Feb 11) Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma. Front oncol [Internet].15. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1520316\/full [cited 2025 Jul 11]","DOI":"10.3389\/fonc.2025.1520316"},{"issue":"3","key":"5522_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3171\/2022.6.PEDS22108","volume":"30","author":"UW Thomale","year":"2022","unstructured":"Thomale UW, Gnekow AK, Kandels D, Bison B, Hern\u00e1iz Driever P, Witt O et al. (2022) Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG, 2004 cohort. J Neurosurg Pediatr 30(3):316\u2013329. https:\/\/doi.org\/10.3171\/2022.6.PEDS22108","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"5522_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/neuonc\/noad195","volume":"26","author":"J Fangusaro","year":"2024","unstructured":"Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O et al. (2024 Jan 5) Pediatric low-grade glioma: state-of-the-art and ongoing challenges. Neuro-Oncol 26(1):25\u201337","journal-title":"Neuro-Oncol"},{"issue":"3","key":"5522_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/jcp-2023-209318","volume":"78","author":"RH Ali","year":"2025","unstructured":"Ali RH, Almanabri M, Ali NY, Alsaber AR, Khalifa NM, Hussein R et al. (2025 Mar) Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients. J Clin Pathol 78(3):177\u2013186","journal-title":"J Clin Pathol"},{"issue":"10","key":"5522_CR8","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s00381-024-06430-8","volume":"40","author":"C Kotch","year":"2024","unstructured":"Kotch C, De Blank P, Gutmann DH, Fisher MJ (2024 Oct) Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions. Childs Nerv Syst 40(10):3241\u20133250","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"5522_CR9","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","volume":"173","author":"P Cambiaso","year":"2017","unstructured":"Cambiaso P, Galassi S, Palmiero M, Mastronuzzi A, Del Bufalo F, Capolino R et al. (2017 Sep) Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Am J Med Genet A 173(9):2353\u20132358","journal-title":"Am J Med Genet A"},{"key":"5522_CR10","doi-asserted-by":"crossref","unstructured":"Yvone GM, Breunig JJ (2024 Jan 22) Pediatric low-grade glioma models: advances and ongoing challenges. Front oncol [Internet]. 13. Available from https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1346949\/full. [cited 2025 Jul 11]","DOI":"10.3389\/fonc.2023.1346949"},{"issue":"12","key":"5522_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1590\/1806-9282.64.12.1129","volume":"64","author":"CB Tavares","year":"2018","unstructured":"Tavares CB, Gomes-Braga FDCS, Sousa EB, Borges US, Esc\u00f3rcio-Dourado CS, Silva-Sampaio JPD et al. (2018 Dec) Evaluation of estrogen receptor expression in low-grade and high-grade astrocytomas. Rev Assoc M\u00e9dica Bras 64(12):1129\u20131133","journal-title":"Rev Assoc M\u00e9dica Bras"},{"issue":"7","key":"5522_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1590\/1806-9282.20210360","volume":"67","author":"CB Tavares","year":"2021","unstructured":"Tavares CB, Fdcsag B, Sousa EB, Hacsd M, Jnpdo B (2021 Jul) Evaluation of progesterone receptor expression in low- and high-grade astrocytomas. Rev Assoc M\u00e9dica Bras 67(7):975\u2013978","journal-title":"Rev Assoc M\u00e9dica Bras"},{"key":"5522_CR13","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhao N, Khan R, Yang HM, Zhang C, Wang S et al. (2024 Sep 27) The prognostic significance of androgen receptor expression in gliomas. Sci Rep [Internet]. 14(1). Available from: https:\/\/www.nature.com\/articles\/s41598-024-72284-4. cited 2025 Jul 11","DOI":"10.1038\/s41598-024-72284-4"},{"key":"5522_CR14","doi-asserted-by":"crossref","unstructured":"; 2024) Unlocking estrogen receptor: structural insights into agonists and antagonists for glioblastoma therapy. In: Advances in protein chemistry and structural biology [internet]. Elsevier, pp 1\u201324. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162324000506. cited 2025 Jul 11","DOI":"10.1016\/bs.apcsb.2024.06.001"},{"issue":"22","key":"5522_CR15","doi-asserted-by":"publisher","first-page":"12404","DOI":"10.3390\/ijms222212404","volume":"22","author":"AM Gonz\u00e1lez-Mora","year":"2021","unstructured":"Gonz\u00e1lez-Mora AM, Garcia-Lopez P (2021 Nov 17) Estrogen receptors as molecular targets of endocrine therapy for glioblastoma. Int J Mol Sci 22(22):12404","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5522_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.14791\/btrt.2023.0039","volume":"12","author":"SH Kang","year":"2024","unstructured":"Kang SH, Park HJ, Hyun JW, Gwak HS (2024) Spontaneous regression of glioma-mimicking brainstem lesion in a child: A case report. Brain Tumor Res Treat 12(1):58","journal-title":"Brain Tumor Res Treat"},{"issue":"1","key":"5522_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/children10010115","volume":"10","author":"A De Lucio Delgado","year":"2023","unstructured":"De Lucio Delgado A, Villegas Rubio JA, I R-G, J PG (2023 Jan 5) Effect of the use of gnrh analogs in low-grade cerebral glioma. Children 10(1):115","journal-title":"Children"},{"issue":"1","key":"5522_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-018-2851-3","volume":"139","author":"A Van Westrhenen","year":"2018","unstructured":"Van Westrhenen A, Senders JT, Martin E, DiRisio AC, Broekman MLD (2018 Aug) Clinical challenges of glioma and pregnancy: a systematic review. J Neurooncol 139(1):1\u201311","journal-title":"J Neurooncol"},{"issue":"3","key":"5522_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ana.21888","volume":"67","author":"J Pallud","year":"2010","unstructured":"Pallud J, Mandonnet E, Deroulers C, Fontaine D, Badoual M, Capelle L et al. (2010 Mar) Pregnancy increases the growth rates of world health organization grade II gliomas. Ann Neurol 67(3):398\u2013404","journal-title":"Ann Neurol"},{"issue":"1","key":"5522_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/2016.10.JNS16710","volume":"128","author":"S Peeters","year":"2018","unstructured":"Peeters S, Pag\u00e8s M, Gauchotte G, Miquel C, Cartalat-Carel S, Guillamo JS et al. (2018 Jan) Interactions between glioma and pregnancy: insight from a 52-case multicenter series. J Neurosurg 128(1):3\u201313","journal-title":"J Neurosurg"},{"key":"5522_CR21","unstructured":"Emmanuel M, Bokor BR (2025) Tanner Stages. in: StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing. 13. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470280\/. [cited 2025 Jul 11]"},{"key":"5522_CR22","doi-asserted-by":"crossref","unstructured":"Fangusaro J, Witt O, Hern\u00e1iz Driever P, Bag AK, De Blank P, Kadom N et al. (2020 Jun) Response assessment in paediatric low-grade glioma: recommendations from the Response assessment in pediatric neuro-oncology (RAPNO) working group. The Lancet Oncol 21(6):e305\u201316","DOI":"10.1016\/S1470-2045(20)30064-4"},{"key":"5522_CR23","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Arenas A, Pe\u00f1a-Ortiz M\u00c1, Hansberg-Pastor M-S V, Baranda-\u00c1vila, Nava-Castro N, K et al. (2015 Mar 1) PKC\u03b1 and PKC\u03b4 activation regulates transcriptional activity and degradation of progesterone receptor in human astrocytoma cells. Endocrinology 156(3):1010\u20131022","DOI":"10.1210\/en.2014-1137"},{"key":"5522_CR24","doi-asserted-by":"crossref","unstructured":"Michmerhuizen AR, Spratt DE, Pierce LJ, Speers CW (2020 Sep 25) Are we there yet? Understanding androgen receptor signaling in breast cancer. Npj Breast Cancer [Internet]. 6(1). Available from: https:\/\/www.nature.com\/articles\/s41523-020-00190-9. cited 2025 Jul 20","DOI":"10.1038\/s41523-020-00190-9"},{"issue":"6","key":"5522_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1159\/000526464","volume":"95","author":"JS Fuqua","year":"2022","unstructured":"Fuqua JS, Eugster EA (2022) History of puberty: normal and precocious. Horm Res Paediatr 95(6):568\u2013578","journal-title":"Horm Res Paediatr"},{"key":"5522_CR26","doi-asserted-by":"publisher","first-page":"117473","DOI":"10.1016\/j.biopha.2024.117473","volume":"180","author":"A Boye","year":"2024","unstructured":"Boye A, Osei SA, Brah AS (2024 Nov) Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers. Biomed Pharmacother 180:117473","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05522-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:15:46Z","timestamp":1778224546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05522-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5522"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05522-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8535463\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the local Ethics Committee. Due to the retrospective nature of the study, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}